SCHEMBL5350841

SCHEMBL5350841

CNCC(OCOC)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.41
SLC6A4 P31645 5/20 0.40
SLC6A2 P23975 4/20 0.39
CYP19A1 P11511 2/20 0.36
SLC6A3 Q01959 1/20 0.35
TAAR1 Q96RJ0 2/20 0.34
ADRB1 P08588 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRB3 P13945 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 1/20 0.33
MITF O75030 1/20 0.33
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
GPR35 Q9HC97 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367825 0.82 AOC3 (0.54) AOC3SLC6A4SLC6A2TAAR1ADRB1
SCHEMBL5350835 0.81 AOC3 (0.38) AOC3SLC6A4SLC6A2CYP19A1SLC6A3
SCHEMBL5215845 0.79 AOC3 (0.44) AOC3SLC6A4SLC6A2CYP19A1SLC6A3
SCHEMBL5350840 0.73 AOC3 (0.42) AOC3CYP19A1ALDH1A1HTTMAPT
SCHEMBL6416831 0.70 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3TAAR1ADRB1
SCHEMBL5358876 0.69 TAAR1 (0.42) AOC3SLC6A4SLC6A2SLC6A3TAAR1
SCHEMBL2294173 0.67 KDM4E (0.68) AOC3SLC6A4SLC6A2SLC6A3TAAR1
SCHEMBL3443558 0.67 KDM4E (0.68) AOC3SLC6A4SLC6A2SLC6A3TAAR1
SCHEMBL5360488 0.67 DPP4 (0.41) AOC3SLC6A4SLC6A2SLC6A3TAAR1
SCHEMBL2299016 0.67 KDM4E (0.68) AOC3SLC6A4SLC6A2SLC6A3TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217723-B2 Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. EISAI CO., LTD. (JP) 2007-05-15 US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227959-A1 Heterocyclic compound having oxime group STAT6, HRH4, HRH2 AOC3 522/4885SLC6A4 4330/4885SLC6A2 4708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.